(Q37063803)

18 August 2017

0 references

1 reference

title

Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection (English)

1 reference

18 August 2017

0 references

0 references

0 references

1 reference

Abdel Aziz M Shaheen

1

1 reference

18 August 2017

Robert P Myers

series ordinal

2

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

9

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

43-51

1 reference

Hepatitis C in the HIV-Infected Person

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Controversies in liver biopsy: who, where, when, how, why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Diagnostic usefulness of percutaneous liver biopsy in HIV-infected patients with fever of unknown origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Meta-analysis of diagnostic test accuracy assessment studies with varying number of thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

The diagnostic odds ratio: a single indicator of test performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0901-43

21 January 2018

Identifiers

DOI

10.1310/HCT0901-43

1 reference

18 August 2017

1 reference